These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
953 related items for PubMed ID: 19011430
1. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H. J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [Abstract] [Full Text] [Related]
2. Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands. Pechlivanoglou P, Vehof J, van Agthoven M, de Jong-van den Berg LT, Postma MJ. Clin Ther; 2010 Jan; 32(1):108-18. PubMed ID: 20171417 [Abstract] [Full Text] [Related]
8. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study. Barrio P, Batalla A, Castellví P, Hidalgo D, García M, Ortiz A, Grande I, Pons A, Parellada E. Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986 [Abstract] [Full Text] [Related]
9. Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia. Arunpongpaisal S, Srisurapanont M, Kongsakon R, Kitiwattanagul K, Samanwongthai U. J Med Assoc Thai; 2010 Mar; 93(3):343-50. PubMed ID: 20420110 [Abstract] [Full Text] [Related]
13. Does oral antipsychotic pre-treatment influence outcome of a switch to long-acting injectable risperidone in patients with schizophrenia? Schmauss M, Diekamp B, Gerwe M, Schreiner A, Ibach B. Pharmacopsychiatry; 2010 Mar; 43(2):73-80. PubMed ID: 20131207 [Abstract] [Full Text] [Related]
14. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome. Lloyd K, Latif MA, Simpson S, Shrestha KL. Hum Psychopharmacol; 2010 Apr; 25(3):243-52. PubMed ID: 20373476 [Abstract] [Full Text] [Related]
15. Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada. Lammers L, Zehm B, Williams R. BMC Psychiatry; 2013 May 30; 13():155. PubMed ID: 23718192 [Abstract] [Full Text] [Related]
16. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients. Girardi P, Serafini G, Pompili M, Innamorati M, Tatarelli R, Baldessarini RJ. Pharmacopsychiatry; 2010 Mar 30; 43(2):66-72. PubMed ID: 20099224 [Abstract] [Full Text] [Related]
20. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. Se Hyun Kim, Dong Chung Jung, Yong Min Ahn, Yong Sik Kim. J Psychopharmacol; 2010 Jul 30; 24(7):981-6. PubMed ID: 19942641 [Abstract] [Full Text] [Related] Page: [Next] [New Search]